Sharemasterindia.com: Wockhardt shares surged as much as 4 per cent to hit intraday high of Rs 1,453.05 on Monday after reports suggested that the company got approval for a new analgesic drug from US Food & Drug Administration (USFDA).
As per the media reports Wockhardt's new analgesic drug Oxycodone Hydrochloride has got approval from the USFDA. The new drug approval will add to company's revenues going ahead, analysts said.
As of 10.30 a.m. Wockhardt shares traded 2.85 per cent higher at Rs 1,439.25 apiece with 89,000 shares already changing hands compared to its two-week average volume of 2.55 lakh shares.
